Topics

Regenxbio, Pfizer enter global licensing agreement for gene therapies

06:24 EDT 1 Aug 2019 | SmartBrief

Pfizer and Regenxbio have signed a non-exclusive international license, including sublicensing rights, to develop and commerc -More

Original Article: Regenxbio, Pfizer enter global licensing agreement for gene therapies

NEXT ARTICLE

More From BioPortfolio on "Regenxbio, Pfizer enter global licensing agreement for gene therapies"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...